title: Ethical issues of human germ-cell therapy: a preparation for public discussion.
abstract: Public debate over the use of techniques that result in heritable changes to human germ cells (i.e., sperm and ova), called germ-cell gene interventions, lags far behind the development of such therapies. Such a debate is particularly needed now because the first steps in somatic-cell, or non-heritable, gene therapy have taken place and may accelerate the beginning of germ-cell gene therapy trials. Because germ-cell therapy affects future generations, its moral status differs considerably from that of somatic-cell therapy. To stimulate and inform public discussion, the authors review the major ethical arguments for and against germ-cell therapy that are found in the literature. (These arguments include the dangers of "playing God," of moving on the "slippery slope" to germ-cell manipulations for enhancement rather than therapy, and of causing irreversible changes to the genomes of future generations.) They demonstrate that these arguments do not apply uniquely to such therapy, since most of the properties of germ-cell therapy are present in other medical interventions or elsewhere in social interactions. For example, there are many examples of human activities that are irreversible and have effects on future generations. However, this lack of uniqueness does not necessarily imply that the moral status of germ-cell gene therapy is unique, or that it should be banned forever. The public, and especially health policymakers, researchers, and clinicians, must reflect on and discuss the issues outlined in this article before efforts are made to introduce changes into the germ cells of human beings.
authors.affiliation: Clinical Trials Research Group, Biomedical Ethics Unit, McGill University Faculty of Medicine, Montreal, Quebec, Canada. szebimre@net.sote.hu
authors.forename: I
authors.initials: I
authors.lastname: Szebik
authors.forename: K C
authors.initials: KC
authors.lastname: Glass
mesh_terms: D004992:Ethics, Medical; D005788:Gene Pool; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000009:adverse effects; D005854:Germ Cells; D006801:Humans